메뉴 건너뛰기




Volumn 87, Issue 1, 2011, Pages 17-21

Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL THERAPY; ARTICLE; CONDOM; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; NETHERLANDS; PATIENT MONITORING; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK REDUCTION; SEXUAL INTERCOURSE; SIMULATION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 78751669179     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2010.042622     Document Type: Article
Times cited : (23)

References (29)
  • 1
    • 0442268112 scopus 로고    scopus 로고
    • A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    • AIDS Clinical Trials Group 320 Study Team
    • Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
    • (1997) N Engl J Med , vol.337 , pp. 725-733
    • Hammer, S.M.1    Squires, K.E.2    Hughes, M.D.3
  • 2
    • 0033576816 scopus 로고    scopus 로고
    • Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
    • Study 006 Team
    • Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999;341:1865-73.
    • (1999) N Engl J Med , vol.341 , pp. 1865-1873
    • Staszewski, S.1    Morales-Ramirez, J.2    Tashima, K.T.3
  • 3
    • 76649092701 scopus 로고    scopus 로고
    • UNAIDS. Report on the Global AIDS epidemic, http://www.unaids.org/en/ knowledge/HIVdata/globalreport/2008/2008-global-report.asp, 2008.
    • (2008) Report on the Global AIDS Epidemic
  • 4
    • 43049128496 scopus 로고    scopus 로고
    • Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
    • Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008;371:1603-11.
    • (2008) Lancet , vol.371 , pp. 1603-1611
    • Jahn, A.1    Floyd, S.2    Crampin, A.C.3
  • 5
    • 64349118898 scopus 로고    scopus 로고
    • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies
    • When To Start Consortium
    • When To Start Consortium, Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;373:1352-63.
    • (2009) Lancet , vol.373 , pp. 1352-1363
    • Sterne, J.A.1    May, M.2    Costagliola, D.3
  • 6
    • 33746512140 scopus 로고    scopus 로고
    • The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
    • DOI 10.1016/S0140-6736(06)69162-9, PII S0140673606691629
    • Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531-6. (Pubitemid 44142776)
    • (2006) Lancet , vol.368 , Issue.9534 , pp. 531-536
    • Montaner, J.S.1    Hogg, R.2    Wood, E.3    Kerr, T.4    Tyndall, M.5    Levy, A.R.6    Harrigan, P.R.7
  • 7
    • 58149097694 scopus 로고    scopus 로고
    • Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model
    • Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.
    • (2009) Lancet , vol.373 , pp. 48-57
    • Granich, R.M.1    Gilks, C.F.2    Dye, C.3
  • 8
    • 0034732201 scopus 로고    scopus 로고
    • Viral load and heterosexual transmission of human immunodeficiency virus type 1
    • Rakai Project Study Group
    • Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
    • (2000) N Engl J Med , vol.342 , pp. 921-929
    • Quinn, T.C.1    Wawer, M.J.2    Sewankambo, N.3
  • 9
    • 47049122773 scopus 로고    scopus 로고
    • Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
    • Vernazza P, Hirschel B, Bernasconi E, et al. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses 2008;89:165-9.
    • (2008) Bulletin des Médecins Suisses , vol.89 , pp. 165-169
    • Vernazza, P.1    Hirschel, B.2    Bernasconi, E.3
  • 10
    • 67149086831 scopus 로고    scopus 로고
    • The debate continues: Does 'undetectable' mean 'uninfectious'?
    • Vernazza PL. The debate continues: does 'undetectable' mean 'uninfectious'? HIV ther 2009;3:113-16.
    • (2009) HIV Ther , vol.3 , pp. 113-116
    • Vernazza, P.L.1
  • 11
    • 78751659719 scopus 로고    scopus 로고
    • AIDS 2008: The Swiss Statement- The debate continues
    • Available at accessed 29 June 2010
    • National Association of People Living With HIV/AIDS 2008. AIDS 2008: The Swiss Statement- the debate continues, 2009. Available at http://napwa.org.au/ pl/2008/09/aids-2008-the-swiss-statement-the-debate-continues (accessed 29 June 2010).
    • (2009) National Association of People Living with HIV/AIDS 2008
  • 12
    • 49949104062 scopus 로고    scopus 로고
    • Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?
    • Sturmer M, Doerr HW, Berger A, et al. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther 2008;13:729-32.
    • (2008) Antivir Ther , vol.13 , pp. 729-732
    • Sturmer, M.1    Doerr, H.W.2    Berger, A.3
  • 13
    • 47649111041 scopus 로고    scopus 로고
    • Relation between HIV viral load and infectiousness: A model-based analysis
    • Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008;372:314-20.
    • (2008) Lancet , vol.372 , pp. 314-320
    • Wilson, D.P.1    Law, M.G.2    Grulich, A.E.3
  • 14
    • 47649124453 scopus 로고    scopus 로고
    • Risk of HIV transmission in discordant couples
    • Garnett GP, Gazzard B. Risk of HIV transmission in discordant couples. Lancet 2008;372:270-1.
    • (2008) Lancet , vol.372 , pp. 270-271
    • Garnett, G.P.1    Gazzard, B.2
  • 15
    • 68449085124 scopus 로고    scopus 로고
    • Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis
    • Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. Aids 2009;23:1397-404.
    • (2009) Aids , vol.23 , pp. 1397-1404
    • Attia, S.1    Egger, M.2    Muller, M.3
  • 16
    • 68449090720 scopus 로고    scopus 로고
    • Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy
    • Wilson DP. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. Aids 2009;23:1431-3.
    • (2009) Aids , vol.23 , pp. 1431-1433
    • Wilson, D.P.1
  • 17
    • 0242301662 scopus 로고    scopus 로고
    • Mortality and progression to AIDS after starting highly active antiretroviral therapy
    • van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. Aids 2003;17:2227-36.
    • (2003) Aids , vol.17 , pp. 2227-2236
    • Van Sighem, A.I.1    Van De Wiel, M.A.2    Ghani, A.C.3
  • 18
    • 41549159352 scopus 로고    scopus 로고
    • The impact of monitoring HIV patients prior to treatment in resource-poor settings: Insights from mathematical modelling
    • Hallett TB, Gregson S, Dube S, et al. The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med 2008;5:e53.
    • (2008) PLoS Med , vol.5
    • Hallett, T.B.1    Gregson, S.2    Dube, S.3
  • 19
    • 44849110373 scopus 로고    scopus 로고
    • Late entry to HIV care limits the impact of antiretroviral therapy in the Netherlands
    • Smit C, Hallett TB, Lange J, et al. Late entry to HIV care limits the impact of antiretroviral therapy in The Netherlands. PLoS One 2008;3:e1949.
    • (2008) PLoS One , vol.3
    • Smit, C.1    Hallett, T.B.2    Lange, J.3
  • 20
    • 36849064140 scopus 로고    scopus 로고
    • Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
    • Fraser C, Hollingsworth TD, Chapman R, et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A 2007;104:17441-6.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 17441-17446
    • Fraser, C.1    Hollingsworth, T.D.2    Chapman, R.3
  • 21
    • 23244439755 scopus 로고    scopus 로고
    • Estimating the proportion of patients infected with HIV who will die of comorbid diseases
    • Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005;118:890-8.
    • (2005) Am J Med , vol.118 , pp. 890-898
    • Braithwaite, R.S.1    Justice, A.C.2    Chang, C.C.3
  • 22
    • 78751661822 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/, 2008.
    • (2008)
  • 23
    • 69449093803 scopus 로고    scopus 로고
    • Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up
    • Ndiaye B, Ould-Kaci K, Salleron J, et al. Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. AIDS 2009;23:1786-9.
    • (2009) AIDS , vol.23 , pp. 1786-1789
    • Ndiaye, B.1    Ould-Kaci, K.2    Salleron, J.3
  • 24
    • 4744352699 scopus 로고    scopus 로고
    • Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men
    • Stolte IG, de Wit JB, van EA, et al. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS 2004;18:1943-9.
    • (2004) AIDS , vol.18 , pp. 1943-1949
    • Stolte, I.G.1    De Wit, J.B.2    Van, E.A.3
  • 26
    • 0033178369 scopus 로고    scopus 로고
    • Per-contact risk of human immunodeficiency virus transmission between male sexual partners
    • Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150:306-11.
    • (1999) Am J Epidemiol , vol.150 , pp. 306-311
    • Vittinghoff, E.1    Douglas, J.2    Judson, F.3
  • 27
    • 33745115034 scopus 로고    scopus 로고
    • Risk factors for HIV infection among men who have sex with men
    • Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids 2006;20:731-9.
    • (2006) Aids , vol.20 , pp. 731-739
    • Koblin, B.A.1    Husnik, M.J.2    Colfax, G.3
  • 28
    • 39149108828 scopus 로고    scopus 로고
    • Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia
    • Podsadecki TJ, Vrijens BC, Tousset EP, et al. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. J Infect Dis 2007;196:1773-8.
    • (2007) J Infect Dis , vol.196 , pp. 1773-1778
    • Podsadecki, T.J.1    Vrijens, B.C.2    Tousset, E.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.